Clinical Trials on Anti Aging in Belgium
Total 29 results
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
KU LeuvenUniversity Ghent; Research Foundation FlandersActive, not recruitingCognitive AgingBelgium
-
Université Catholique de LouvainCompleted
-
KU LeuvenCompletedHealthy AgingBelgium
-
Hasselt UniversityRecruiting
-
KU LeuvenCompleted
-
Imelda Hospital, BonheidenUniversité Catholique de LouvainRecruitingAging | Hip Fractures | Osteoporosis | Osteoarthritis, Hip | Clonal Hematopoiesis of Indeterminate PotentialBelgium
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
University of LiegeCentre Hospitalier Universitaire de LiegeRecruitingChronic Disease | Aging | Chronic Disease ManagementBelgium
-
Université Catholique de LouvainRecruitingPharmacokinetics | Infection | Infection, Bacterial | Anti-Bacterial Agents | Drug Monitoring | Infections, RespiratoryBelgium
-
University GhentKU Leuven; Research Foundation FlandersRecruitingHealthy Aging | Cognitive Decline | Physical InactivityBelgium
-
Universitaire Ziekenhuizen KU LeuvenRecruitingAging | Overweight and Obesity | Sarcopenic Obesity | Bariatric SurgeryBelgium
-
KU LeuvenRecruitingParkinson Disease | AgingBelgium
-
Universitaire Ziekenhuizen KU LeuvenRecruitingAging | Bariatric Surgery Candidate | Overweight and Obesity | Protein MalabsorptionBelgium
-
University Hospital, GhentRecruitingAlzheimer Disease | Healthy Aging | Mild Cognitive ImpairmentBelgium
-
Universitaire Ziekenhuizen KU LeuvenCompletedQuality of Life | Cognitive Impairment | Aging | Traumatic Brain InjuryBelgium
-
ChemoCentryxCompletedA Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)ANCA-Associated VasculitisUnited States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedVasculitisUnited States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
-
AstraZenecaActive, not recruitingEosinophilic Granulomatous VasculitisUnited States, Canada, France, Italy, Israel, United Kingdom, Japan, Germany, Belgium
-
GlaxoSmithKlineNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With PolyangiitisChurg-Strauss SyndromeUnited States, France, Japan, Spain, Italy, Germany, Canada, Belgium, United Kingdom
-
GlaxoSmithKlineCompletedChurg-Strauss Syndrome | Eosinophilic Granulomatosis With PolyangiitisUnited States, France, Japan, Germany, Canada, United Kingdom, Belgium
-
InflaRx GmbHCompletedGranulomatosis With Polyangiitis (GPA) | Microscopic Polyangiitis (MPA)Germany, Russian Federation, Belgium, France, Spain, Czechia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
-
Scholar Rock, Inc.Active, not recruitingNeuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Anti-myostatin | Spinal Muscular Atrophy Type IIUnited States, Spain, Belgium, Germany, Netherlands, Poland, Italy, France, United Kingdom
-
Scholar Rock, Inc.Active, not recruitingNeuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type 2 | Anti-myostatinUnited States, Germany, Belgium, Spain, United Kingdom, Netherlands, France, Italy, Poland
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedMicroscopic Polyangiitis (MPA) | Granulomatosis With Polyangiitis (Wegener's) (GPA)United States, Belgium, France, United Kingdom, Denmark, Canada, Japan, Australia, New Zealand, Sweden, Czechia, Italy, Greece, Mexico, Norway
-
GlaxoSmithKlineRecruitingEosinophilic Granulomatosis With PolyangiitisCanada, France, Italy, Spain, Belgium, Korea, Republic of, United States, Japan, China, Czechia, Hungary, Israel, Portugal, Poland, Netherlands, United Kingdom, Austria, Argentina, Australia, Brazil, Germany, Sweden
-
University of OxfordAmerican College of Rheumatology; The European League Against Rheumatism (EULAR) and other collaboratorsUnknownGiant Cell Arteritis | Wegener's Granulomatosis | Microscopic Polyangiitis | Polyarteritis Nodosa | Takayasu Arteritis | Churg Strauss SyndromeKorea, Republic of, United States, Germany, Australia, Japan, Ireland, Belgium, Italy, Denmark, Slovenia, Switzerland, Canada, Argentina, Austria, China, Czech Republic, Egypt, Finland, France, Hungary, India, Mexico, Netherlands, New... and more